Patients with acute COPD exacerbations, uncomplicated by acidotic respiratory failure or other medical problems, can be proposed two new models of treatment as an alternative to inpatient hospital care: i) a supported ...
Hear from COPD patients and healthcare professionals Learn More News and Activities Take a look at our events Learn more References: Adeloye D et al. Lancet Respir Med. 2022 May; 10(5):447–458. World Health Organization (WHO). The top 10 causes of death. 2020. Available at: https...
APhilips-funded studydemonstrated that both hospitals and payers can benefit from significant reductions in hospitalizations, readmissions, and healthcare costs by providing patients with NIV therapy at home in the context of a multifaceted program that includes oxygen therapy, respiratory therapist-led ca...
1. Zanaboni P, Dinesen B, Hoaas H,et al. Long-term Telerehabilitation or Unsupervised Training at Home for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Am J Respir Crit Care Med. 2023 Apr 1;207(7):865-875. 2. 2-year telerehabilitation lowers hospitaliza...
The aim of yhe study is to evaluate if the patients with COPD cared for by the Home Care Nursing Service have fewer hospital admissions and shorter lengths of stay. Methods. A quasi-experimental study, on paired samples to compare the data of hospital admissions and lengths of stay in ...
PMA will assist in implementing discharge planning and home services based on your physician’s discharge orders. You and your family count on ongoing support from PMA Learn more or schedule an appointment by calling COPD Transitional Care at916-679-3588....
Don’t wait to find out your risk because treatment options may exist.†If you are diagnosed with alpha-1, there are FDA-approved treatments to consider with your healthcare provider. Not a scientist? Not a problem. It’s simple, quick, and there’s no need to be a scientist—you ca...
Don’t wait to find out your risk because treatment options may exist.†If you are diagnosed with alpha-1, there are FDA-approved treatments to consider with your healthcare provider. Not a scientist? Not a problem. It’s simple, quick, and there’s no need to be a scientist—you ca...
Don’t wait to find out your risk because treatment options may exist.†If you are diagnosed with alpha-1, there are FDA-approved treatments to consider with your healthcare provider. Not a scientist? Not a problem. It’s simple, quick, and there’s no need to be a scientist—you ca...
In the study, 375 patients with COPD were randomly assigned to a home healthcare regimen delivered by an app with remote coaching or to a wait list and usual care. The median age was 69 years. Fifty-nine percent were women. The median FEV1at enrollment was 45% of predicted....